65 related articles for article (PubMed ID: 8741674)
1. [Degradation of topoisomerase II alpha precedes nuclei degeneration during adenovirus E1A-induced apoptosis and is mediated by the activation of the ubiquitin dependent proteolysis system].
Nakajima T
Nihon Rinsho; 1996 Jul; 54(7):1828-35. PubMed ID: 8741674
[TBL] [Abstract][Full Text] [Related]
2. Degradation of topoisomerase IIalpha during adenovirus E1A-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system.
Nakajima T; Morita K; Ohi N; Arai T; Nozaki N; Kikuchi A; Osaka F; Yamao F; Oda K
J Biol Chem; 1996 Oct; 271(40):24842-9. PubMed ID: 8798759
[TBL] [Abstract][Full Text] [Related]
3. Induction of ubiquitin conjugating enzyme activity for degradation of topoisomerase II alpha during adenovirus E1A-induced apoptosis.
Nakajima T; Kimura M; Kuroda K; Tanaka M; Kikuchi A; Seino H; Yamao F; Oda K
Biochem Biophys Res Commun; 1997 Oct; 239(3):823-9. PubMed ID: 9367853
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus E1A-induced apoptosis elicits a steep decrease in the topoisomerase II alpha level during the latent phase.
Nakajima T; Ohi N; Arai T; Nozaki N; Kikuchi A; Oda K
Oncogene; 1995 Feb; 10(4):651-62. PubMed ID: 7862442
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway.
Nakajima T; Morita K; Tsunoda H; Imajoh-Ohmi S; Tanaka H; Yasuda H; Oda K
J Biol Chem; 1998 Aug; 273(32):20036-45. PubMed ID: 9685342
[TBL] [Abstract][Full Text] [Related]
6. Enhanced TRAIL sensitivity by E1A expression in human cancer and normal cell lines: inhibition by adenovirus E1B19K and E3 proteins.
Hu B; Zhu H; Qiu S; Su Y; Ling W; Xiao W; Qi Y
Biochem Biophys Res Commun; 2004 Dec; 325(4):1153-62. PubMed ID: 15555548
[TBL] [Abstract][Full Text] [Related]
7. E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs.
Zhou Z; Jia SF; Hung MC; Kleinerman ES
Cancer Res; 2001 Apr; 61(8):3394-8. PubMed ID: 11309298
[TBL] [Abstract][Full Text] [Related]
8. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
[TBL] [Abstract][Full Text] [Related]
10. E1A specifically enhances sensitivity to topoisomerase IIalpha targeting anticancer drug by up-regulating the promoter activity.
Zhou Z; Guan H; Kleinerman ES
Mol Cancer Res; 2005 May; 3(5):271-5. PubMed ID: 15886298
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic adenovirus-mediated E1A gene therapy induces tumor-cell apoptosis and reduces tumor angiogenesis leading to inhibition of hepatocellular carcinoma growth in animal model.
Ye Z; Wang X; Hao S; Zhong J; Xiang J; Yang J
Cancer Biother Radiopharm; 2006 Jun; 21(3):225-34. PubMed ID: 16918299
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo.
Deng J; Xia W; Hung MC
Oncogene; 1998 Oct; 17(17):2167-75. PubMed ID: 9811448
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism.
Brader KR; Wolf JK; Hung MC; Yu D; Crispens MA; van Golen KL; Price JE
Clin Cancer Res; 1997 Nov; 3(11):2017-24. PubMed ID: 9815592
[TBL] [Abstract][Full Text] [Related]
14. p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing.
Flinterman MB; Mymryk JS; Klanrit P; Yousef AF; Lowe SW; Caldas C; Gäken J; Farzaneh F; Tavassoli M
Oncogene; 2007 Oct; 26(48):6863-74. PubMed ID: 17486071
[TBL] [Abstract][Full Text] [Related]
15. E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines.
Flinterman M; Gäken J; Farzaneh F; Tavassoli M
Oncogene; 2003 Apr; 22(13):1965-77. PubMed ID: 12673202
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
[TBL] [Abstract][Full Text] [Related]
17. E1A oncogene-induced cellular sensitization to immune-mediated apoptosis is independent of p53 and resistant to blockade by E1B 19 kDa protein.
Cook JL; Routes BA; Leu CY; Walker TA; Colvin KL
Exp Cell Res; 1999 Oct; 252(1):199-210. PubMed ID: 10502412
[TBL] [Abstract][Full Text] [Related]
18. Activation of intracellular proteases is an early event in TNF-induced apoptosis.
Voelkel-Johnson C; Entingh AJ; Wold WS; Gooding LR; Laster SM
J Immunol; 1995 Feb; 154(4):1707-16. PubMed ID: 7836755
[TBL] [Abstract][Full Text] [Related]
19. Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.
Cook JL; Walker TA; Worthen GS; Radke JR
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9966-71. PubMed ID: 12119420
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
